Bicocca Open Archive

Logo unimib boa
TODDE, SERGIO CAMILLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.038
AS - Asia 5.339
EU - Europa 3.857
SA - Sud America 631
AF - Africa 120
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 18.000
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.833
VN - Vietnam 1.641
SG - Singapore 1.394
CN - Cina 1.022
IT - Italia 744
DE - Germania 673
HK - Hong Kong 537
RU - Federazione Russa 500
SE - Svezia 488
BR - Brasile 470
IE - Irlanda 306
GB - Regno Unito 242
UA - Ucraina 239
FR - Francia 154
FI - Finlandia 149
IN - India 146
CA - Canada 143
KR - Corea 86
AT - Austria 85
BD - Bangladesh 75
ID - Indonesia 67
AR - Argentina 63
TR - Turchia 54
IQ - Iraq 52
NL - Olanda 50
ZA - Sudafrica 46
PK - Pakistan 40
JP - Giappone 39
ES - Italia 37
DK - Danimarca 36
PL - Polonia 35
SA - Arabia Saudita 35
MX - Messico 32
EC - Ecuador 28
PH - Filippine 26
CO - Colombia 22
BE - Belgio 21
MA - Marocco 17
MY - Malesia 15
CZ - Repubblica Ceca 14
IR - Iran 14
BG - Bulgaria 13
CH - Svizzera 13
UZ - Uzbekistan 13
KE - Kenya 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
RO - Romania 10
TN - Tunisia 10
PE - Perù 8
PT - Portogallo 8
DO - Repubblica Dominicana 7
EG - Egitto 7
KZ - Kazakistan 7
PY - Paraguay 7
TH - Thailandia 7
GR - Grecia 6
JO - Giordania 6
LT - Lituania 6
NP - Nepal 6
OM - Oman 6
SK - Slovacchia (Repubblica Slovacca) 6
AU - Australia 5
AZ - Azerbaigian 5
BO - Bolivia 5
DZ - Algeria 5
EU - Europa 5
HN - Honduras 5
LB - Libano 5
TW - Taiwan 5
ET - Etiopia 4
JM - Giamaica 4
LV - Lettonia 4
MK - Macedonia 4
NG - Nigeria 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SN - Senegal 4
AO - Angola 3
CR - Costa Rica 3
IL - Israele 3
KG - Kirghizistan 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
NI - Nicaragua 3
PA - Panama 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
LY - Libia 2
ME - Montenegro 2
MN - Mongolia 2
PS - Palestinian Territory 2
QA - Qatar 2
RE - Reunion 2
Totale 17.987
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.568
Ashburn 821
Singapore 803
Hong Kong 512
Ho Chi Minh City 510
Hanoi 455
Fairfield 433
San Jose 421
Houston 387
Woodbridge 359
Wilmington 331
Chandler 321
Dublin 288
Jacksonville 247
New York 218
Frankfurt am Main 207
Dearborn 194
Santa Clara 181
Milan 172
Seattle 172
Beijing 159
Los Angeles 146
Dallas 140
Hefei 136
Cambridge 135
Chicago 121
Munich 121
Princeton 112
The Dalles 98
Nanjing 83
Seoul 77
Helsinki 72
Vienna 67
Lauterbourg 62
Da Nang 61
Shanghai 60
Altamura 59
Council Bluffs 54
São Paulo 53
Lawrence 49
Haiphong 48
Jakarta 46
Buffalo 44
Moscow 41
Lachine 39
San Diego 36
Orem 34
Ninh Bình 33
Quận Bình Thạnh 31
Toronto 31
Biên Hòa 30
Boardman 29
Tokyo 29
Guangzhou 27
Ha Long 27
Hải Dương 27
Rome 27
Shenyang 27
Changsha 24
Denver 24
London 24
Nürnberg 24
Thái Nguyên 24
Hebei 23
Can Tho 22
Tianjin 22
Brussels 21
Lissone 21
Warsaw 21
Dhaka 20
Nanchang 20
Falls Church 19
Montreal 19
Turku 19
Andover 18
Chennai 17
Dong Ket 17
Jinan 17
Stockholm 17
Baghdad 16
Fremont 16
Jiaxing 16
Phoenix 16
Salt Lake City 16
Atlanta 15
Brooklyn 15
Bắc Ninh 15
Genoa 15
Jeddah 15
Montréal 15
Ottawa 15
Rio de Janeiro 15
Turin 15
Amsterdam 14
Johannesburg 14
Bologna 13
Quận Một 13
Vinh 13
Bogotá 12
Lahore 12
Totale 11.810
Salva come PNG Salva come JPEG
Nome #
Radio-chemotherapy and metformin selectively modulate the heterogeneous landscape of glioma with ribosome biogenesis, long non coding RNA and immune-escape markers as major player 774
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 547
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 524
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 516
Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: A PET imaging and metabolomics-mass-spectrometry study 507
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 444
Cholinergic ligand [C-11]MP4A: Improved 4-acetoxypiperidine precursor synthesis via LC-APCI/MS characterisation and improved radioligand HPLC purification 438
In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416 435
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 409
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 405
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 387
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 357
Improved synthesis and radiolabeling of [C-11]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 345
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 335
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma 334
Highlight selection of radiochemistry and radiopharmacy developments by editorial board 314
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 310
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation 302
PET imaging and single-cell RNA sequencing glioma microenvironment assessment after RT combined therapy 300
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 296
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies 291
PET radiopharmacy and automation 286
Sperimentazione clinica con radiofarmaci 283
EANM Guideline on the validation of analytical methods for radiopharmaceuticals 277
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells 272
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework 269
Synthesis and carbon-11 labeling of (R)- and (S)-Thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for Positron Emission Tomography 266
Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective β2-adrenergic radioligand 265
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 256
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 254
Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application 251
Quality Control in the Production of Radiopharmaceuticals 251
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 245
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 244
Produzione e verifiche di qualità dei radiofarmaci estemporanei per PET e terapia 242
Rsdiofarmaci marcati con fluoro-18 241
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals 240
Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors 238
European regulations for the introduction of novel radiopharmaceuticals in the clinical setting 236
Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons 233
Sensitive GC-MS method for the determination of specific-activity of 16a[18F]Fluoro-estra-1,3,5(10)-triene-3,17b-diol 232
Systemic and cerebral kinetics of 16α[18F]fluoro-17β-estradiol: A ligand for the in vivo assessment of estrogen receptor binding parameters 231
Preparation of [11C]radioligands with high specific radioactivity on a commercial PET tracer synthesizer 231
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) 231
Synthesis and Biodistribution of (R,S)-[O-Methyl-11C]-1-[3-(5-Methoxy-1,2,3,4-Tetrahydro-1-Naphtalenyl)Propyl]-4-Phenylpiperazine (PNU-157760), A Putative Radioligand for 5-HT1A Receptors 230
Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals 226
Synthesis and in vivo evaluation of [C-11]CGP62349, a new GABA(B) receptor antagonist 219
Automation of [C-11]acyl chloride syntheses using commercially available C-11-modules 218
Intake risk and dose evaluation methods for workers in radiochemistry labs of a medical cyclotron facility 214
Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time 201
High yield synthesis of [11C]-acetone through selective quenching of methyl lithium 199
Guidance on validation and qualification of processes and operations involving radiopharmaceuticals 187
PET in psychopharmacology 185
Synthesis of [O-methyl-11c]fluvoxamine-a potential serotonin uptake site radioligand 184
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals 182
Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A2A receptor system using positron emission tomography [2] 179
From radiotracer to radiopharmaceutical: a philosophical approach 174
EANM guideline on quality risk management for radiopharmaceuticals 162
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals 160
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken' 152
Classificazione ambientale 152
Highlight selection of radiochemistry and radiopharmacy developments by editorial board 150
Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals 148
A PET follow-up study of recovery after stroke in acute aphasics 147
Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: A European perspective 135
Mild synthesis of [N-methyl-11C]-isovaleroyl-(L)-carnitine. The usefulness of a tritium approach. 130
Automated fluorine-18 radiolabeling via an alkyne–azide cycloaddition reaction on a dual peptide-functionalized liposome surface for in vivo PET imaging 94
Application of molecular imaging as potential prognostic biomarker for triple-negative breast cancer (TNBC) 28
Totale 18.400
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.798
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021250 0 0 0 0 0 0 0 0 0 0 106 144
2021/20221.021 89 111 168 136 35 59 62 69 49 59 77 107
2022/20231.344 164 387 84 134 100 197 26 78 71 19 57 27
2023/20241.109 44 40 56 39 147 310 211 40 85 12 8 117
2024/20252.572 137 251 120 98 217 179 202 158 239 341 207 423
2025/20266.887 1.558 742 508 736 704 356 913 311 510 535 14 0
Totale 18.400